Topics
- Page Path
-
- HOME
- TOPICS
- Topics
- Correspondence
- Correspondence on editorial regarding “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
- Mehrangiz Dezhbord, Kyun-Hwan Kim
- Clin Mol Hepatol. 2024;30(4):1028-1030. Published online July 9, 2024
-
View: 1409 Download: 84 Crossref: 1
- Correspondence to editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”
- Qi Wang, Qingfa Bu, Haoming Zhou, Ling Lu
- Clin Mol Hepatol. 2024;30(4):1026-1027. Published online July 8, 2024
-
View: 986 Download: 45
- Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”
- Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
- Clin Mol Hepatol. 2024;30(4):1023-1025. Published online July 1, 2024
-
View: 1269 Download: 44 Crossref: 2
- The role of SPP1 in MASLD pathogenesis: Therapeutic insights into ursolic acid’s mechanisms of action: Correspondence to editorial on “Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease”
- Yiyuan Zheng, Zhekun Xiong, Lina Zhao, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Fengbin Liu, Yong Li
- Clin Mol Hepatol. 2024;30(4):1019-1022. Published online July 8, 2024
-
View: 1191 Download: 58
- Correspondence to editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
- Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
- Clin Mol Hepatol. 2024;30(4):1016-1018. Published online May 20, 2024
-
View: 1224 Download: 38
- Correspondence to editorial on “Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment”
- Do Seon Song, Dong Joon Kim
- Clin Mol Hepatol. 2024;30(4):1012-1015. Published online June 18, 2024
-
View: 1180 Download: 20
- Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
- Su Bin Lim, Hyo Jung Cho
- Clin Mol Hepatol. 2024;30(4):1009-1011. Published online May 20, 2024
-
View: 1235 Download: 65 Crossref: 1
- Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”
- Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
- Clin Mol Hepatol. 2024;30(4):1005-1008. Published online May 30, 2024
-
View: 1360 Download: 59
- Correspondence to editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”
- Jiaorong Qu, Le Wang, Xiaojiaoyang Li
- Clin Mol Hepatol. 2024;30(4):1002-1004. Published online May 17, 2024
-
View: 1280 Download: 51
- Correspondence to editorial on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
- Vy H. Nguyen, Mindie H. Nguyen
- Clin Mol Hepatol. 2024;30(4):1000-1001. Published online August 5, 2024
-
View: 898 Download: 39
- Correspondence to editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”
- Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
- Clin Mol Hepatol. 2024;30(4):997-999. Published online July 29, 2024
-
View: 918 Download: 38
- Correspondence to editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
- Xiaoqian Xu, Hong You, Jidong Jia, Yuanyuan Kong
- Clin Mol Hepatol. 2024;30(4):994-996. Published online July 23, 2024
-
View: 1025 Download: 31 Web of Science: 1 Crossref: 1
- Correspondence to editorial on “Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging”
- Haeryoung Kim, Dong Ho Lee, Yoon Jung Hwang
- Clin Mol Hepatol. 2024;30(4):992-993. Published online August 5, 2024
-
View: 932 Download: 38 Crossref: 1
- Correspondence to editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
- Hayeon Kim, Min Jeong Park, Myeong Gyu Kim, Kyungim Kim
- Clin Mol Hepatol. 2024;30(4):989-991. Published online August 27, 2024
-
View: 898 Download: 37 Crossref: 1
- Correspondence to editorial on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”
- Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu
- Clin Mol Hepatol. 2024;30(4):987-988. Published online April 19, 2024
-
View: 1295 Download: 39
- Letter to the Editor
- Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
- Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
- Clin Mol Hepatol. 2024;30(4):982-986. Published online August 27, 2024
-
View: 1087 Download: 56 Web of Science: 1 Crossref: 1
- Differences in major adverse cardiovascular events of metabolic dysfunction-associated steatotic liver disease by race and ethnicity: Letter to the editor on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
- Hui-Chin Chang, Wen-Chieh Liao, Yi-Jen Fang, Shiu-Jau Chen, Shuo-Yan Gau
- Clin Mol Hepatol. 2024;30(4):978-981. Published online August 5, 2024
-
View: 1067 Download: 54 Crossref: 2
- Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”
- Yixuan Zhu, Xiaoyan Ma, Wenjing Ni, Yee Hui Yeo, Junping Shi, Jie Li
- Clin Mol Hepatol. 2024;30(4):974-977. Published online July 4, 2024
-
View: 1500 Download: 74
- Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”
- Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu, Terry Cheuk-Fung Yip
- Clin Mol Hepatol. 2024;30(4):970-973. Published online July 4, 2024
-
View: 1379 Download: 57
- Metabolic dysfunction-associated fatty liver disease related hepatocellular carcinoma in China: An increasing problem: Letter to the edior on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
- Xiangyu Wu, Wenjing Ni, Qianqian Chen, Junping Shi, Jie Li
- Clin Mol Hepatol. 2024;30(4):965-969. Published online June 18, 2024
-
View: 1806 Download: 85
- Equivalent prevalence and progression of chronic kidney disease in non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
- Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
- Clin Mol Hepatol. 2024;30(4):962-964. Published online May 20, 2024
-
View: 1486 Download: 100 Web of Science: 1 Crossref: 4
- Changing from NAFLD to MASLD: Cumulative incidence of gallstones between patients with NAFLD and those with MASLD in Asia
- Shuhei Fukunaga, Tomoyuki Nakane, Michita Mukasa, Hidetoshi Takedatsu, Takumi Kawaguchi
- Clin Mol Hepatol. 2024;30(4):959-961. Published online May 10, 2024
-
View: 1375 Download: 69 Web of Science: 2 Crossref: 3
- Original Article
- Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK
- Kwanjoo Lee, Jaeyu Park, Jinseok Lee, Myeongcheol Lee, Hyeon Jin Kim, Yejun Son, Sang Youl Rhee, Lee Smith, Masoud Rahmati, Jiseung Kang, Hayeon Lee, Yeonjung Ha, Dong Keon Yon
- Clin Mol Hepatol. 2024;30(4):943-958. Published online August 29, 2024
-
View: 1993 Download: 134 Web of Science: 3 Crossref: 2
- The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study
- Keungmo Yang, Sunghwan Kim, Hyun Yang, Sheng-Min Wang, Bumseok Jeong, Hyun Kook Lim, Si Hyun Bae
- Clin Mol Hepatol. 2024;30(4):929-942. Published online August 27, 2024
-
View: 1602 Download: 113
- Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma
- Yu-Hang Ye, Hao-Yang Xin, Jia-Li Li, Ning Li, Si-Yuan Pan, Long Chen, Jing-Yue Pan, Zhi-Qiang Hu, Peng-Cheng Wang, Chu-Bin Luo, Rong-Qi Sun, Jia Fan, Jian Zhou, Zheng-Jun Zhou, Shao-Lai Zhou
- Clin Mol Hepatol. 2024;30(4):914-928. Published online August 6, 2024
-
View: 1860 Download: 180 Crossref: 1
- KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression
- Young Hoon Jung, Yun Ji Lee, Tam Dao, Kyung Hee Jung, Junjie Yu, Ah-Reum Oh, Yelin Jeong, HyunJoon Gi, Young Un Kim, Dongryeol Ryu, Michele Carrer, Utpal B. Pajvani, Sang Bae Lee, Soon-Sun Hong, KyeongJin Kim
- Clin Mol Hepatol. 2024;30(4):895-913. Published online August 5, 2024
-
View: 2146 Download: 281
- Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan
- Chung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, Chih-Wen Wang, Tyng-Yuan Jang, Po-Cheng Liang, Tzu-Chun Lin, Pei-Chien Tsai, Yu-Ju Wei, Ming-Lun Yeh, Ming-Yen Hsieh, Chao-Kuan Huang, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu
- Clin Mol Hepatol. 2024;30(4):883-894. Published online July 29, 2024
-
View: 1585 Download: 105
- TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD
- Baokai Sun, Xiaoqian Ding, Jie Tan, Jie Zhang, Xueru Chu, Shuimi Zhang, Shousheng Liu, Zhenzhen Zhao, Shiying Xuan, Yongning Xin, Likun Zhuang
- Clin Mol Hepatol. 2024;30(4):863-882. Published online July 26, 2024
-
View: 2041 Download: 240 Web of Science: 1
- Gut microbiome and metabolome signatures in liver cirrhosis-related complications
- Satya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, Sang Yoon Lee, Seol Hee Song, Jeoung Su Kim, Jeong Ha Park, Min Ju Kim, Dong-Hoon Yang, Hyunjoon Park, Sung-Min Won, Jin-Ju Jeong, Ki-Kwang Oh, Jung A Eom, Kyeong Jin Lee, Sang Jun Yoon, Young Lim Ham, Gwang Ho Baik, Dong Joon Kim, Ki Tae Suk
- Clin Mol Hepatol. 2024;30(4):845-862. Published online July 25, 2024
-
View: 4275 Download: 961 Web of Science: 2 Crossref: 4
- DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease
- Amal Magdy, Hee-Jin Kim, Hanyong Go, Jun Min Lee, Hyun Ahm Sohn, Keeok Haam, Hyo-Jung Jung, Jong-Lyul Park, Taekyeong Yoo, Eun-Soo Kwon, Dong Hyeon Lee, Murim Choi, Keon Wook Kang, Won Kim, Mirang Kim, on behalf of the Innovative Target Exploration of NAFLD (ITEN) Consortium
- Clin Mol Hepatol. 2024;30(4):824-844. Published online July 25, 2024
-
View: 2214 Download: 287
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
